Big Molecule Watch
- Now Available! Updated Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., 2024-2025 December 9, 2024 Sarah Clarke
- Biocon Announces FDA Approval of Ustekinumab Biosimilar December 7, 2024 Stephanie Dusaban Gonzales
- Update on Pending Denosumab BPCIA Litigations December 4, 2024 Harrison Gunn
- European Commission Approves Samsung Bioepis and Biogen’s Aflibercept Biosimilar November 27, 2024 Daniel Farraye
- FDA approves CAR-T Cell Therapy for Refractory B-cell Precursor Acute Lymphoblastic Leukemia November 19, 2024 Sam Herron
- Amgen Files BPCIA Complaint Against Accord Biopharma Regarding Denosumab Biosimilar November 18, 2024 Zachariah Holmes
- Celltrion Launches STEQEYMA (ustekinumab) in Germany and the Netherlands November 14, 2024 Alison Siedor
- FDA Accepts BLA for Shanghai Henlius Biotech’s and Organon’s HLX14, a Denosumab Biosimilar November 7, 2024 Yoko Bian
- Daewoong and Celltrion to Market Denosumab Biosimilar in Korea November 7, 2024 Emma Murray
- EMA Accepts Marketing Authorization Application for Alvotech’s AVT05 (golimumab) November 6, 2024 Tara Thigpen
BioPharma Reporter
- Eli Lilly invests $3bn in injectable drug manufacturing facility December 10, 2024
- Relation and GSK join forces to advance fibrotic diseases and osteoarthritis therapies December 10, 2024
- GSK and Muna Therapeutics partner to develop new treatments for Alzheimer’s December 10, 2024
- Cell and gene therapy access model launches in US December 5, 2024
- Antag Therapeutics raises $84 million to advance its weight loss drug into the clinic December 5, 2024
- Spyre Therapeutics launches Phase 1 trials for its extended half-life IBD therapy December 3, 2024
- PTC Therapeutics boosted by Novartis rights deal for Huntington’s program December 3, 2024
- Eisai and Biogen launch Alzheimer’s treatment in South Korea December 2, 2024 Liza Laws
- Roche acquires CAR-T developer Poseida Therapeutics for $1.5 billion November 28, 2024
- Amgen announces positive Phase 2 results for its GLP-1-GIP weight loss drug November 28, 2024